Exploring Biomarkers Beyond Exercise Testing: The Impact of Smoking on Cardiovascular and Pulmonary Health among CKD Patients
Novelty in Biomedicine,
Vol. 12 No. 3 (2024),
6 July 2024
,
Page 95- 103
https://doi.org/10.22037/nbm.v12i3.44576
Abstract
Background: Chronic Kidney Disease (CKD) patients often face complex health challenges, including cardiovascular and pulmonary issues. Smoking is a recognized risk factor for these conditions, but its specific impact on CKD patients remains less understood.
Materials and Methods: In this cross-sectional study, we investigated the relationship between smoking habits and cardiopulmonary health among CKD patients. We examined baseline characteristics, including demographics, medical history, and biochemical markers, in a cohort of CKD patients. Cardiopulmonary parameters were assessed during exercise testing, including oxygen consumption, ventilation rates, ventilation-perfusion matching markers, and oxygen saturation levels.
Results: Our findings revealed no statistically significant differences in cardiopulmonary parameters between smokers and non-smokers within the CKD patient population. This suggests that the relationship between smoking and exercise capacity in CKD patients is complex and influenced by multiple factors. Our analysis of demographics, comorbidities, and medication history provided critical context for interpreting these results.
Conclusion: This study contributes to our understanding of the intricate relationship between smoking habits and cardiopulmonary health in CKD patients. While smoking is recognized as a risk factor, its specific impact on exercise capacity within this population may be influenced by individual variables. Further research is needed to explore these relationships in larger and more diverse cohorts. These findings underscore the importance of considering multiple variables when assessing the impact of smoking on the health of CKD patients.
- Renal insufficiency
- Smoking
- Cardiovascular risk
- Cardiopulmonary health
How to Cite
References
Reitsma MB, Fullman N, Ng M, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 2017;389(10082):1885-906.
Jha P, Chaloupka FJ, Corrao M, Jacob B. Reducing the burden of smoking world‐wide: effectiveness of interventions and their coverage. Drug and alcohol review. 2006;25(6):597-609.
Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y. Cigarette smoking and chronic kidney diseases. Hypertension Research. 2012;35(3):261-5.
Xia J, Wang L, Ma Z, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrology Dialysis Transplantation. 2017;32(3):475-87.
Coresh J. Update on the burden of CKD. Journal of the American Society of Nephrology: JASN. 2017;28(4):1020.
Roger M, Osuna Ortega A, De Gracia Guindo MdC, et al. CKD: The burden of disease invisible to research funders. 2021.
Mortensen ME, Wong L-Y, Osterloh JD. Smoking status and urine cadmium above levels associated with subclinical renal effects in US adults without chronic kidney disease. International journal of hygiene and environmental health. 2011;214(4):305-10.
Chaikijurajai T, Wu Y, Grodin J, Harb S, Jaber W, Tang W. Prognostic value of the hemodynamic gain index in different groups of patients undergoing cardiopulmonary exercise stress testing. European Heart Journal. 2021;42(Supplement_1):ehab724. 2672.
So R, Andersen ZJ, Chen J, et al. Long-term exposure to air pollution and mortality in a Danish nationwide administrative cohort study: Beyond mortality from cardiopulmonary disease and lung cancer. Environment international. 2022;164:107241.
Lim K, McGregor G, Coggan AR, Lewis GD, Moe SM. Cardiovascular functional changes in chronic kidney disease: integrative physiology, pathophysiology and applications of cardiopulmonary exercise testing. Frontiers in Physiology. 2020;11:572355.
Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarød K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? American journal of kidney diseases. 2006;47(3):396-405.
Parvathaneni K, Surapaneni A, Ballew SH, et al. Association between midlife physical activity and incident kidney disease: The Atherosclerosis Risk in Communities (ARIC) study. American Journal of Kidney Diseases. 2021;77(1):74-81.
Guo C, Tam T, Bo Y, Chang L-y, Lao XQ, Thomas GN. Habitual physical activity, renal function and chronic kidney disease: a cohort study of nearly 200 000 adults. British Journal of Sports Medicine. 2020;54(20):1225-30.
Salin K, Kankaanpää A, Hirvensalo M, et al. Smoking and physical activity trajectories from childhood to midlife. International journal of environmental research and public health. 2019;16(6):974.
Palmer M, Sutherland J, Barnard S, et al. The effectiveness of smoking cessation, physical activity/diet and alcohol reduction interventions delivered by mobile phones for the prevention of non-communicable diseases: a systematic review of randomised controlled trials. PloS one. 2018;13(1):e0189801.
de Borba AT, Jost RT, Gass R, et al. The influence of active and passive smoking on the cardiorespiratory fitness of adults. Multidisciplinary respiratory medicine. 2014;9:1-8.
Laukkanen JA, Pukkala E, Rauramaa R, Mäkikallio TH, Toriola AT, Kurl S. Cardiorespiratory fitness, lifestyle factors and cancer risk and mortality in Finnish men. European journal of cancer. 2010;46(2):355-63.
Barros Neto TLd, Tebexreni AS, Tambeiro VL. Aplicações práticas da ergoespirometria no atleta. Rev. Soc. Cardiol. Estado de Säo Paulo. 2001:695-705.
Laukkanen JA, Laaksonen D, Lakka TA, et al. Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. The American journal of cardiology. 2009;103(11):1598-604.
- Abstract Viewed: 41 times
- pdf Downloaded: 24 times